Matches in SemOpenAlex for { <https://semopenalex.org/work/W4377096713> ?p ?o ?g. }
Showing items 1 to 61 of
61
with 100 items per page.
- W4377096713 abstract "
 CADTH reimbursement reviews are comprehensive assessments of the clinical effectiveness and cost-effectiveness, as well as patient and clinician perspectives, of a drug or drug class.
 The assessments inform non-binding recommendations that help guide the reimbursement decisions of Canada's federal, provincial, and territorial governments, with the exception of Quebec.
 This review assesses 177Lu vipivotide tetraxetan (Pluvicto), solution for injection, 1 GBq/mL (27 mCi/mL) at calibration.
 Indication: The treatment of adults with prostate-specific membrane antigen-positive metastatic castration-resistant prostate cancer who have received at least 1 androgen receptor pathway inhibitor and taxane-based chemotherapy.
" @default.
- W4377096713 created "2023-05-20" @default.
- W4377096713 creator A5043032954 @default.
- W4377096713 date "2023-05-18" @default.
- W4377096713 modified "2023-09-29" @default.
- W4377096713 title "Lutetium (¹⁷⁷Lu) Vipivotide Tetraxetan (Pluvicto)" @default.
- W4377096713 doi "https://doi.org/10.51731/cjht.2023.655" @default.
- W4377096713 hasPublicationYear "2023" @default.
- W4377096713 type Work @default.
- W4377096713 citedByCount "0" @default.
- W4377096713 crossrefType "journal-article" @default.
- W4377096713 hasAuthorship W4377096713A5043032954 @default.
- W4377096713 hasBestOaLocation W43770967131 @default.
- W4377096713 hasConcept C121608353 @default.
- W4377096713 hasConcept C126322002 @default.
- W4377096713 hasConcept C143998085 @default.
- W4377096713 hasConcept C160735492 @default.
- W4377096713 hasConcept C17744445 @default.
- W4377096713 hasConcept C199539241 @default.
- W4377096713 hasConcept C2777511904 @default.
- W4377096713 hasConcept C2777899217 @default.
- W4377096713 hasConcept C2778971682 @default.
- W4377096713 hasConcept C2779703844 @default.
- W4377096713 hasConcept C2780192828 @default.
- W4377096713 hasConcept C29456083 @default.
- W4377096713 hasConcept C530470458 @default.
- W4377096713 hasConcept C535046627 @default.
- W4377096713 hasConcept C71924100 @default.
- W4377096713 hasConceptScore W4377096713C121608353 @default.
- W4377096713 hasConceptScore W4377096713C126322002 @default.
- W4377096713 hasConceptScore W4377096713C143998085 @default.
- W4377096713 hasConceptScore W4377096713C160735492 @default.
- W4377096713 hasConceptScore W4377096713C17744445 @default.
- W4377096713 hasConceptScore W4377096713C199539241 @default.
- W4377096713 hasConceptScore W4377096713C2777511904 @default.
- W4377096713 hasConceptScore W4377096713C2777899217 @default.
- W4377096713 hasConceptScore W4377096713C2778971682 @default.
- W4377096713 hasConceptScore W4377096713C2779703844 @default.
- W4377096713 hasConceptScore W4377096713C2780192828 @default.
- W4377096713 hasConceptScore W4377096713C29456083 @default.
- W4377096713 hasConceptScore W4377096713C530470458 @default.
- W4377096713 hasConceptScore W4377096713C535046627 @default.
- W4377096713 hasConceptScore W4377096713C71924100 @default.
- W4377096713 hasIssue "5" @default.
- W4377096713 hasLocation W43770967131 @default.
- W4377096713 hasOpenAccess W4377096713 @default.
- W4377096713 hasPrimaryLocation W43770967131 @default.
- W4377096713 hasRelatedWork W2094570582 @default.
- W4377096713 hasRelatedWork W2111028754 @default.
- W4377096713 hasRelatedWork W2263206436 @default.
- W4377096713 hasRelatedWork W2507499293 @default.
- W4377096713 hasRelatedWork W2735900144 @default.
- W4377096713 hasRelatedWork W2768013934 @default.
- W4377096713 hasRelatedWork W2776356588 @default.
- W4377096713 hasRelatedWork W2811161792 @default.
- W4377096713 hasRelatedWork W3014214351 @default.
- W4377096713 hasRelatedWork W3164096504 @default.
- W4377096713 hasVolume "3" @default.
- W4377096713 isParatext "false" @default.
- W4377096713 isRetracted "false" @default.
- W4377096713 workType "article" @default.